X

Health: OpenDNA establishes China gateway for Petrus Pharmaceuticals

Consumer tech business OpenDNA (ASX:OPN) has been manoeuvring for a while now to get distribution channels set up into China.…

Kogan goes where others fear to tread, dives into energy retail

Kogan (ASX:KGN) will be one of, if not the first non-telecommunication businesses in Australia to add electricity sales to its…

Corporate: Alchemia has finally found its new opportunity – and it’s hemp

It has been a few lean years at Alchemia (ASX: ACL). In October 2014 the Phase III trial of an…

Gold: Artemis taps corporate advisor to tackle ‘numerous’ joint venture, takeover offers

Australian gold prices are going crazy; but small cap gold stocks are going cheap. Which means now is the perfect…

Uranium: Hylea takes a $10m punt; shares rocket over 130pc

Battery metals player Hylea Metals (ASX:HCO) likes the uranium market so much it is buying Paladin Energy’s (ASX:PDN) stake in…

Top 10 at 10: These ASX stocks have jumped ahead this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens…

When the Nullarbor heats up, these are the small caps with first-mover advantage

Sirius’ Nova, Sandfire’s DeGrussa or Rio Tinto's Winu – there’s something about frontier-type mineral discoveries which capture the collective imagination.…

Money Talks: These diagnostic imaging plays paint a pretty picture for investors

Money Talks is Stockhead’s regular drill down into what stocks investors are looking at right now. We’ll tap our extensive…

Barry FitzGerald: Diatreme Resources’ true grit to be tested as zircon deal looms

Don’t make the mistake that a princely market price of 1c for a market cap of $15m means Diatreme Resources…

VIDEO: 90 Seconds With…Will Robinson, Encounter Resources

Got 90 seconds? Then listen to Encounter Resources MD Will Robinson give us an update on the company at this…

MyFiziq is helping consumers put the personal in personalised medicine

Special Report: Personalised medicine -- therapy and treatment that takes into account an individual patient’s characteristics -- is one of…

Dr Boreham’s Crucible: Next Science wants you for the war on bacteria

In the never-ending battle against bacteria, Next Science (ASX:NXS) has adopted a ‘take no prisoners’ approach in eradicating the bodily…